- Home
- GPRO vs KOD Comparison
GPRO vs KOD Comparison
Compare GPRO & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPRO
- KOD
- Stock Information
- Founded
- GPRO 2004
- KOD 2009
- Country
- GPRO United States
- KOD United States
- Employees
- GPRO N/A
- KOD N/A
- Industry
- GPRO Industrial Machinery/Components
- KOD Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GPRO Consumer Discretionary
- KOD Health Care
- Exchange
- GPRO Nasdaq
- KOD Nasdaq
- Market Cap
- GPRO 194.6M
- KOD 198.4M
- IPO Year
- GPRO 2014
- KOD 2018
- Fundamental
- Price
- GPRO $2.07
- KOD $9.25
- Analyst Decision
- GPRO
- KOD Hold
- Analyst Count
- GPRO 0
- KOD 4
- Target Price
- GPRO N/A
- KOD $11.75
- AVG Volume (30 Days)
- GPRO 10.4M
- KOD 628.4K
- Earning Date
- GPRO 11-06-2025
- KOD 11-13-2025
- Dividend Yield
- GPRO N/A
- KOD N/A
- EPS Growth
- GPRO N/A
- KOD N/A
- EPS
- GPRO N/A
- KOD N/A
- Revenue
- GPRO $746,731,000.00
- KOD N/A
- Revenue This Year
- GPRO N/A
- KOD N/A
- Revenue Next Year
- GPRO $9.72
- KOD N/A
- P/E Ratio
- GPRO N/A
- KOD N/A
- Revenue Growth
- GPRO N/A
- KOD N/A
- 52 Week Low
- GPRO $0.40
- KOD $1.92
- 52 Week High
- GPRO $2.37
- KOD $11.60
- Technical
- Relative Strength Index (RSI)
- GPRO 71.18
- KOD 52.06
- Support Level
- GPRO $1.44
- KOD $9.41
- Resistance Level
- GPRO $1.73
- KOD $10.20
- Average True Range (ATR)
- GPRO 0.20
- KOD 0.77
- MACD
- GPRO 0.04
- KOD -0.11
- Stochastic Oscillator
- GPRO 91.49
- KOD 41.20
About GPRO GoPro Inc.
GoPro Inc is a United States-based company that is principally engaged in designing and providing cameras, mounts and accessories, lifestyle gear, applications, and subscriptions and services. The company sells products across the world through retailers, distributors, and on GoPro.com. Its hardware products are designed and developed in the United States, France, China, and Romania, and a majority of the manufacturing is outsourced to contract manufacturers located in China, Thailand, and Vietnam. Geographically, the company generates maximum revenue from the Americas, followed by Europe, Middle East and Africa (EMEA), and Asia and Pacific (APAC) region.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.